Radiation Recall Dermatitis After Capecitabine in a Patient With Triple Negative Breast Cancer.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 34157449.
- Also identified by DOI 10.1016/j.prro.2021.06.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A case is descibed of radiation recall dermatitis in a patient treated with adjuvant radiation therapy followed by capecitabine for triple negative breast cancer with residual disease after neoadjuvant chemotherapy.
Medical subject headings
- Breast Neoplasms
- Radiodermatitis
- Triple Negative Breast Neoplasms